Impact of lowering confirmatory test cutoff value in pre-enlistment urine cannabinoids screening: About five years' experience in the French Gendarmerie

Journal of Analytical Toxicology

Volumn 36, Issue 8, 2012, Pages 569-574

  Lecompte, Yannick ^a   Perrin, Martine ^a   Salle, Sophie ^a   Roussel, Olivier ^a  

^a INSTITUT GÉOGRAPHIQUE NATIONAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; TETRAHYDROCANNABINOLIC ACID;

ARTICLE; CANNABIS SMOKING; MASS FRAGMENTOGRAPHY; PREDICTIVE VALUE; SENSITIVITY ANALYSIS; URINALYSIS;

EID: 84867669345     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks067     Document Type: Article

References (26)

1. Gheorghiev, C., Arvers, P., de Montleau, F., Fidelle, G., Queyriaux, B., Verret, C. (2009) Cannabis in the army: Between past and topicality. Annals of Medical Psychology, 167, 429-436.
2. Ministry of Defence. (2008) Ministerial instruction No. 22000/DEF/GEND/RH on the standards of medical fitness of military personnel of the Gendarmerie.
3. European Workplace Drug Testing Society. European laboratory guidelines for legally defensible workplace drug testing: Urine drug testing. http://www.ewdts.org/guidelines/EWDTSGuidelines.pdf (accessed September 2011).
4. United States Department of Health and Human Services. (2008) Substance Abuse and Mental Health Services Administration. Mandatory guidelines for federal workplace drug testing programs. Federal Register, 73, 71858-71907.
5. Legleye, S., Le Nézet, O., Spilka, S., Beck, F. (2008) Drug use among adolescents and young adults between 2000 and 2005, France. Bulletin Épidémiologique Hebdomadaire., 13, 89-92.
6. Huestis, M.A., Mitchell, J.M., Cone, E.J. (1994) Lowering the federally mandated cannabinoid immunoassay cutoff increases truepositive results. Clinical Chemistry, 40, 729-733.
7. Rowland, B.J., Irving, J., Keith, E.S. (1994) Increased detection of marijuana use with a 50 micrograms/L urine screening cutoff. Clinical Chemistry, 40, 2114-2115.
8. Madhavaram, H., Couch, R.A. (2010) Utilization of a detection level of 25ng/mL for cannabinoids in urine using a CEDIA THCPLUS immunoassay: Application of this cut-off to urines of school children. Forensic Science International, 198, 28-30.
9. Wingert, W.E. (1997) Lowering cutoffs for initial and confirmation testing for cocaine and marijuana: Large-scale study of effects on the rates of drug-positive results. Clinical Chemistry, 43, 100-103.
10. Liu, R.H., Edwards, C., Baugh, L.D., Weng, J.L., Fyfe, M.J., Walia, A.S. (1994) Selection of an appropriate initial test cutoff concentration for workplace drug urinalysis-cannabis example. Journal of Analytical Toxicology, 18, 65-70.
11. Hubert, P., Rozet, E., Boulanger, B., Dewé, W., Laurentie, M., Dubois, N. et al. (2006) Harmonisation of validation strategies and estimation of the associated uncertainty in the framework of assay laboratories accreditation. Acta Clinica Belgica, 1, 54-56.
12. Feinberg, M., Boulanger, B., Dewe, W., Hubert, P. (2004) New advances in method validation and measurement uncertainty aimed at improving the quality of chemical data. Analytical and Bioanalytical Chemistry, 380, 502-514.
13. Niedbala, R.S., Kardos, K.W., Fritch, D.F., Kunsman, K.P., Blum, K.A., Newland, G.A. et al. (2005) Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. Journal of Analytical Toxicology, 29, 607-615.
14. Rohrich, J., Schimmel, I., Zorntlein, S., Becker, J., Drobnik, S., Kaufmann, T. et al. (2010) Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to cannabis smoke in a coffee shop. Journal of Analytical Toxicology, 34, 196-203.
15. Moeller, K.E., Lee, K.C., Kissack, J.C. (2008) Urine drug screening: Practical guide for clinicians. Mayo Clinic Proceedings, 83, 66-76.
16. Peace, M.R., Tarnai, L.D., Poklis, A. (2000) Performance evaluation of four on-site drug testing devices for detection of drugs of abuse in urine. Journal of Analytical Toxicology, 24, 589-594.
17. Kadehjian, L.J. (2001) Performance of five non-instrumented urine drug-testing devices with challenging near-cutoff specimens. Journal of Analytical Toxicology, 25, 670-679.
18. Samyn, N., Areschka, V., Verstraete, A. (2000) Evaluation of roadside drug testing equipment. Ann. Toxicol. Anal., 12, 105-115.
19. Boucher, A., Vilette, P., Crassard, N., Bernard, N., Descotes, J. (2009) Urinary toxicological screening: Analytical interference between niflumic acid and cannabis. Archives of Pediatrics, 16, 1457-1460.
20. Goulle, J.P., Saussereau, E., Lacroix, C. (2008) Delta-9-tetrahydrocannabinol pharmacokinetics. Annales Pharmaceutiques Françaises, 66, 232-244.
21. Skopp, G., Potsch, L. (2004) An investigation of the stability of free and glucuronidated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in authentic urine samples. Journal of Analytical Toxicology, 28, 35-40.
22. Huestis, M.A. (2007) Human cannabinoid pharmacokinetics. Chemistry and Biodiversity, 4, 1770-1804.
23. Dasgupta, A. (2007) The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine. American Journal of Clinical Pathology, 128, 491-503.
24. Fraser, A.D., Zamecnik, J. (2003) Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators. Therapeutic Drug Monitoring, 25, 723-727.
25. Hayden, J.W. (1991) Passive inhalation of marijuana smoke: A critical review. Journal of Substance Abuse, 3, 85-90.
26. Niedbala, S., Kardos, K., Salamone, S., Fritch, D., Bronsgeest, M., Cone, E.J. (2004) Passive cannabis smoke exposure and oral fluid testing. Journal of Analytical Toxicology, 28, 546-552.